KALA BIO, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.5 USD | -0.15% |
|
-3.79% | -7.14% |
| May. 17 | HC Wainwright Adjusts Kala Pharmaceuticals Price Target to $18 From $21, Maintains Buy Rating | MT |
| Apr. 02 | HC Wainwright Trims KALA BIO's Price Target to $21 From $22, Keeps Buy Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 18.34M | - | - | - | - | - | |
| 723B | ||||||
| 595B | ||||||
| 369B | ||||||
| 332B | ||||||
| 282B |
- Stock Market
- Equities
- KALA Stock
- Charts KALA BIO, Inc.
- Sector Chart
